Department of Dermatology, Royal London Hospital, Whitechapel, London, E1 1BB, U.K.
Br J Dermatol. 2013 Sep;169(3):607-10. doi: 10.1111/bjd.12392.
Delusional infestation (DI) is the persistent belief of pathogenic infestation of the skin or body, without objective medical evidence. Treatment for symptoms of delusions can be particularly challenging, especially when patients are difficult to engage and adverse to the possibility of a nonskin disorder. To date there has been no study to evaluate patient adherence to DI treatment.
To assess the adherence of patients with DI to psychotropic and/or dermatological medication.
Sixty-nine consecutive patients with DI receiving treatment from our psychodermatology clinic were identified from a departmental database. Patient adherence to treatment was assessed via medical records, patient letters and a telephone questionnaire.
Eighteen of 69 patients were noncontactable, reducing the sample size to 51. Forty-nine of 51 patients were receiving psychotropic medication (96%). Psychotropic agents included second-generation antipsychotics and antidepressants. Twenty-nine of 49 patients were adherent to psychotropic medication. Secondary nonadherence was reported by 18 of 49 patients. Two patients were nonadherent to psychotropic medication. Adherence to dermatological medication was high (96%).
This is the first study to assess the adherence of patients with DI to treatment. The majority of patients on psychotropic medication were compliant. Secondary nonadherence was mainly due to drug side-effects. The adherence to dermatological medications is high. Thorough counselling of patients with regard to indication, dosage and side-effects of psychotropic agents can improve adherence to medication and is an essential part of the treatment process for DI.
妄想性寄生虫病(DI)是一种持续存在的病理性皮肤或身体感染的信念,而没有客观的医学证据。治疗妄想症状可能特别具有挑战性,尤其是当患者难以接触并且对非皮肤疾病的可能性持反对态度时。迄今为止,还没有研究评估患者对 DI 治疗的依从性。
评估 DI 患者对精神药物和/或皮肤科药物的依从性。
从我们的精神皮肤科诊所的部门数据库中确定了 69 例连续接受 DI 治疗的患者。通过病历、患者信件和电话问卷调查评估患者的治疗依从性。
在 69 例患者中,有 18 例无法联系,使样本量减少到 51 例。51 例患者中有 49 例正在服用精神药物(96%)。精神药物包括第二代抗精神病药和抗抑郁药。在 49 例患者中,有 29 例患者对精神药物有依从性。在 49 例患者中,有 18 例报告了二级不依从。有 2 例患者不依从精神药物。皮肤科药物的依从性很高(96%)。
这是第一项评估 DI 患者治疗依从性的研究。大多数服用精神药物的患者都遵守医嘱。二级不依从主要是由于药物副作用所致。对精神药物的适应症、剂量和副作用进行彻底的患者咨询可以提高药物依从性,是 DI 治疗过程的重要组成部分。